The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.
Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.
According to unaudited, pro forma data, Panomics would have added $10.7 million to Affy's total revenues for the nine months ended Sept. 30, 2008, and $11 million to the company's top line in fiscal year 2007.
Sylentis will perform the initial clinical trial on its own in Spain for logistical reasons, but expects to later test the topically administered drug in other countries, including the US, according to a company official.
The grants will help pay for research into the function of conserved miRNAs in plants, the role the non-coding RNAs play in human T- and B-cell activation, the impact of miRNAs in brain cancer, and how miRNAs affect the aging process.